<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02469753</url>
  </required_header>
  <id_info>
    <org_study_id>CHUBX2014/36</org_study_id>
    <nct_id>NCT02469753</nct_id>
  </id_info>
  <brief_title>Interest of Continuous Non-Steroidal Anti-Inflammatory Drug Treatment in Ankylosing Spondylitis Patients Treated by Anti-TNF Therapy in the Prevention of Radiographic Outcomes</brief_title>
  <acronym>STOP</acronym>
  <official_title>Interest of Continuous Non-Steroidal Anti-Inflammatory Drug Treatment in Ankylosing Spondylitis Patients Treated by Anti-TNF Therapy in the Prevention of Radiographic Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Bordeaux</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ankylosing spondylitis (AS) is a frequent chronic inflammatory rheumatic disease that affects
      the axial skeleton, starting in the sacroiliac joints and spreading to the spine in most
      patients. Non-steroidal anti-inflammatory drugs (NSAIDs) are the primary treatment for AS.
      Even if the use of anti-TNF agents has demonstrated good clinical efficacy in controlling
      inflammation, in contrast to other conditions such as rheumatoid arthritis and psoriatic
      arthritis, anti-TNF treatment has failed to demonstrate any benefit on the structural
      progression of AS, some data even suggesting that it may accelerate the formation of
      syndesmophytes that seems to be an independent process of TNF. Conversely, NSAIDs inhibit
      ossification phenomena independently of their anti-inflammatory properties, owing to a
      specific action on bone formation via prostaglandin inhibition.

      Several features suggest that a continuous NSAID therapy is needed, in addition to anti-TNF
      treatment, to prevent syndesmophyte formation in AS patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 23, 2015</start_date>
  <completion_date type="Anticipated">June 2021</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of patients who show a significant radiographic progression between the two randomised groups of patients</measure>
    <time_frame>24 month after the begin of the treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Radiologic evolution between-group comparison</measure>
    <time_frame>At the inclusion (Day 0) and 24 month after after the inclusion (Day 0)(begin of the treatment)</time_frame>
    <description>This measure is a composite with :
MRI
Clinical evolution of patients
Quantitative analysis of mSASSS score</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">225</enrollment>
  <condition>Ankylosing Spondylitis</condition>
  <arm_group>
    <arm_group_label>Patients treated with anti-TNF and continuous daily NSAIDs</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients treated with anti-TNF and NSAIDs on demand</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>NSAIDs</intervention_name>
    <description>continuous daily</description>
    <arm_group_label>Patients treated with anti-TNF and continuous daily NSAIDs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>NSAIDs</intervention_name>
    <description>on demand</description>
    <arm_group_label>Patients treated with anti-TNF and NSAIDs on demand</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>anti-TNF</intervention_name>
    <arm_group_label>Patients treated with anti-TNF and continuous daily NSAIDs</arm_group_label>
    <arm_group_label>Patients treated with anti-TNF and NSAIDs on demand</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients aged over 18 years old

          -  Patients who fulfil 1984 modified New York criteria for ankylosing spondylitis:

          -  SA patients with indications for anti-TNF treatment initiation according to the French
             society of Rheumatology guidelines.

          -  Being affiliated to a health insurance system

          -  Having signed an informed consent form (later than the day of inclusion and before any
             examination required by the research)

        Exclusion Criteria:

          -  Patients who present another chronic systemic inflammatory disorder, different from
             ankylosing spondylitis.

          -  Patients who present contraindications to treatment with NSAIDs.

          -  Patient with daily corticosteroid treatment at a dosage ≥ 10 mg/day

          -  Pregnant or breastfeeding women

          -  Contra-indication to MRI (pacemakers, aneurysm clips, artificial heart valves, ear
             implants, metal fragments or foreign objects in the eyes, skin or body,
             claustrophobia) or refusing to undergo MRI

          -  Women that refuse to an effective contraception method for all the study duration
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rodolphe THIEBAUT, Prof</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital Bordeaux, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thierry SCHAEVERBEKE, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Bordeaux, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thierry SCHAEVERBEKE, Prof</last_name>
    <phone>(0)556795556</phone>
    <phone_ext>+33</phone_ext>
    <email>thierry.schaeverbeke@chu-bordeaux.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Thomas BARNETCHE, PhD</last_name>
    <phone>(0)557820493</phone>
    <phone_ext>+33</phone_ext>
    <email>thomas.barnetche@chu-bordeaux.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service de rhumatologie - CHU d'Amiens</name>
      <address>
        <city>Amiens</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vincent GOEB, Prof</last_name>
      <email>goebvince@yahoo.fr</email>
    </contact>
    <investigator>
      <last_name>Vincent GOEB, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de rhumatologie - CHU de Besançon</name>
      <address>
        <city>Besancon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel WENDLING, Prof</last_name>
      <email>dwendling@chu-besancon.fr</email>
    </contact>
    <investigator>
      <last_name>Daniel WENDLING, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de Rhumatologie - CHU de Bordeaux</name>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thierry SCHAEVERBEKE, Prof</last_name>
      <email>thierry.schaeverbeke@chu-bordeaux.fr</email>
    </contact>
    <contact_backup>
      <last_name>Thomas BARNETCHE, PhD</last_name>
      <email>thomas.barnetche@chu-bordeaux.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Thierry SCHAEVERBEKE, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>service de rhumatologie - AP-HP - Hôpital Ambroise Paré</name>
      <address>
        <city>Boulogne-billancourt</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Maria-Antonietta D'AGOSTINO, Prof</last_name>
      <email>maria-antonietta.dagostino@apr.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Maria-Antonietta D'AGOSTINO, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de rhumatologie - CHU de Brest</name>
      <address>
        <city>Brest</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alain SARAUX, Prof</last_name>
      <email>alain.saraux@chu-brest.fr</email>
    </contact>
    <investigator>
      <last_name>Alain SARAUX, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>service de rhumatologie - CH de Cahors</name>
      <address>
        <city>Cahors</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Slim LASSOUED, MD</last_name>
      <email>lassoued3@ch-cahors.fr</email>
    </contact>
    <investigator>
      <last_name>Slim LASSOUED, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>service de rhumatologie - CH Le Mans</name>
      <address>
        <city>Le Mans</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmanuelle DERNIS, MD</last_name>
      <email>edernis@ch-lemans.fr</email>
    </contact>
    <investigator>
      <last_name>Emmanuelle DERNIS, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>service de rhumatologie - CHU de Limoges</name>
      <address>
        <city>Limoges</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Philippe BERTIN, Prof</last_name>
      <email>philippe.bertin@chu-limoges.fr</email>
    </contact>
    <investigator>
      <last_name>Philippe BERTIN, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>service de rhumatologie - CHU de Montpellier</name>
      <address>
        <city>Montpellier</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cedric LUKAS, Prof</last_name>
      <email>c-lukas@chu-montpellier.fr</email>
    </contact>
    <investigator>
      <last_name>Cedric LUKAS, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>service de rhumatologie - CHU de Nancy</name>
      <address>
        <city>Nancy</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Damien LOEUILLE, Prof</last_name>
      <email>d.loeuille@chu-nancy.fr</email>
    </contact>
    <investigator>
      <last_name>Damien LOEUILLE, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de rhumatologie - CHU de Nice</name>
      <address>
        <city>Nice</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liana EULLER-ZIEGLER, Prof</last_name>
      <email>euller-ziegler.l@chu-nice.fr</email>
    </contact>
    <investigator>
      <last_name>Liana EULLER-ZIEGLER, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>service de rhumatologie - CHR d'Orléans</name>
      <address>
        <city>Orleans</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carine SALLIOT, MD</last_name>
      <email>carine.salliot@chr-orleans.fr</email>
    </contact>
    <investigator>
      <last_name>Carine SALLIOT, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>service de rhumatologie - AP-HP - Hôpital Henri Mondor</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pascal CLAUDEPIERRE, Prof</last_name>
      <email>pascal.claudepierre@hmn.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Pascal CLAUDEPIERRE, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de rhumatologie - AP-HP - Hôpital Lariboisière</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pascal RICHETTE, Prof</last_name>
      <email>pascal.richette@lrb.aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>service de rhumatologie - AP-HP- Hôpital La Pitié Salpétrière</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laure GOSSEC, Prof</last_name>
      <email>laure.gossec@psl.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Laure GOSSEC, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>service de rhumatologuie - CH de Pau</name>
      <address>
        <city>PAU</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurence LEQUEN, MD</last_name>
      <email>laurence.lequen@ch-pau.fr</email>
    </contact>
    <investigator>
      <last_name>Laurence LEQUEN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>service de rhumatologie - CHU de Rouen</name>
      <address>
        <city>Rouen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier VITTECOQ, Prof</last_name>
      <email>olivier.vittecoq@chu-rouen.fr</email>
    </contact>
    <investigator>
      <last_name>Olivier VITTECOQ, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>service de rhumatologie - CHU de Saint-Etienne</name>
      <address>
        <city>Saint-etienne</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hubert MAROTTE, Prof</last_name>
      <email>hubert.marotte@chu-st-etienne.fr</email>
    </contact>
    <investigator>
      <last_name>Hubert MAROTTE, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>service de rhumatologie - CHU de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacques-Eric GOTTENBERG, Prof</last_name>
      <email>jacques-eric.gottenberg@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Jacques-Eric GOTTENBERG, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>service de rhumatologie - CHU de Toulouse</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adeline RUYSSEN-WITRAND, MD</last_name>
      <email>ruyssen-witrand.a@chu-toulouse.fr</email>
    </contact>
    <investigator>
      <last_name>Adeline RUYSSEN-WITRAND, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de rhumatologie - CHU de Tours</name>
      <address>
        <city>Tours</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe GOUPILLE, Prof</last_name>
      <email>goupille@med.univ-tours.fr</email>
    </contact>
    <investigator>
      <last_name>Philippe GOUPILLE, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>service de Rhumatologie - CH Princesse Grace</name>
      <address>
        <city>Monaco</city>
        <country>Monaco</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier BROCQ, MD</last_name>
    </contact>
    <investigator>
      <last_name>Olivier BROCQ, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
    <country>Monaco</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 9, 2015</study_first_submitted>
  <study_first_submitted_qc>June 10, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 11, 2015</study_first_posted>
  <last_update_submitted>May 7, 2018</last_update_submitted>
  <last_update_submitted_qc>May 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>NSAIDs</keyword>
  <keyword>Anti-TNF</keyword>
  <keyword>syndesmophytes</keyword>
  <keyword>mSASSS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spondylitis</mesh_term>
    <mesh_term>Spondylitis, Ankylosing</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Inflammatory Agents</mesh_term>
    <mesh_term>Anti-Inflammatory Agents, Non-Steroidal</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

